Chemo-Free hope: new combo shows promise for leukemia patients
NCT ID NCT02666898
First seen Jan 05, 2026 · Last updated Apr 30, 2026 · Updated 20 times
Summary
This study tested a chemotherapy-free treatment for people with untreated chronic lymphocytic leukemia (CLL). Participants received two drugs (ibrutinib and obinutuzumab) for nine months. If their cancer was in deep remission, they continued ibrutinib alone; if not, they got additional chemo. The goal was to see how well the treatment controlled the disease without standard chemotherapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sponsor FILO
Tours, 37054, France
Conditions
Explore the condition pages connected to this study.